CAM
LMAT icon

Cresset Asset Management’s LeMaitre Vascular LMAT Stock Holding History

Cresset Asset Management’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5,701
Closed -$530K – 2011
2024
Q3 		$530K Sell
5,701
-178
-3% -$15.4K ﹤0.01% 1486
2024
Q2 		$484K Sell
5,879
-649
-10% -$47.7K ﹤0.01% 1458
2024
Q1 		$433K Buy
6,528
+214
+3% +$13.2K ﹤0.01% 1408
2023
Q4 		$358K Buy
6,314
+412
+7% +$21.6K ﹤0.01% 1405
2023
Q3 		$322K Sell
5,902
-1
-0% -$59 ﹤0.01% 1411
2023
Q2 		$397K Buy
+5,903
New +$360K ﹤0.01% 1389
2021
Q4 		– Sell
-6,839
Closed -$363K – 1218
2021
Q3 		$363K Buy
6,839
+2
+0% +$113 ﹤0.01% 753
2021
Q2 		$417K Buy
6,837
+134
+2% +$7.12K 0.01% 624
2021
Q1 		$327K Sell
6,703
-1,036
-13% -$48.6K 0.01% 639
2020
Q4 		$313K Sell
7,739
-2
-0% -$71 0.01% 544
2020
Q3 		$252K Buy
+7,741
New +$232K ﹤0.01% 566
2019
Q2 		– Sell
-571
Closed -$18K – 1139
2019
Q1 		$18K Buy
571
+506
+778% +$13.5K ﹤0.01% 1041
2018
Q4 		$2K Buy
+65
New +$1.77K ﹤0.01% 1332

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cresset Asset Management's LMAT Position: Q4 2024 in Review

Cresset Asset Management sold out of LeMaitre Vascular (LMAT) in Q4 2024, closing a stake of 5,701 shares — an estimated $530K sold.

Cresset Asset Management first reported a position in LMAT in Q4 2018 and held it in 13 quarters. The position peaked at $530K in Q3 2024. 307 funds tracked by Wall St. Rank hold LMAT as of Q4 2024.

  • Cresset Asset Management reported no remaining LeMaitre Vascular position as of Q4 2024 after selling out during the quarter.
  • Cresset Asset Management sold 5,701 LeMaitre Vascular shares in Q4 2024, an estimated $530K.
  • Cresset Asset Management first reported a position in LeMaitre Vascular in Q4 2018 and held it in 13 quarters.
  • Cresset Asset Management's LeMaitre Vascular position peaked at $530K in Q3 2024.
  • 307 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2024.

Based on Cresset Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.